A human monoclonal antibody blocking SARS-CoV-2 infection

A human monoclonal antibody blocking SARS-CoV-2 infection
Author(s):
Rutuja Survase, Anjum Saudagar, Runali bharti, Renuka R. Deshpande
Keywords:
COVID-19 , monoclonal antibody
Abstract
The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV). This cross-neutralizing antibody targets a communal epitope on these viruses and offers potential for prevention and treatment of COVID-19.
Article Details
Unique Paper ID: 149461 Publication Volume & Issue: Volume 6, Issue 12 Page(s): 396 - 401
Article Preview & Download

Share This Article

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024

Last Date: 15th March 2024

IJIRT.org enables door in research by providing high quality research articles in open access market.

Send us any query related to your research on editor@ijirt.org